Key result
Corticosteroids and targeted hematologic therapy achieve complete resolution of eosinophilic myocarditis without residual fibrosis.
Why the study?
Eosinophilic myocarditis is a rare inflammatory condition of the myocardium often associated with systemic or hematologic disorders.
Case Report (n=1)
Early multimodality cardiac imaging and coordinated cardio-hematologic management with corticosteroids and targeted therapy can lead to complete resolution of eosinophilic myocarditis without residual fibrosis in patients with PDGFRA-rearranged myeloid neoplasm.
May support reversibility with combined therapy in select cases; hypothesis-generating and requires prospective validation in PDGFRA-rearranged myeloid neoplasms.
Eosinophilic myocarditis is a rare inflammatory condition caused by eosinophilic infiltration of the myocardium, often associated with systemic or hematologic disorders. We report a 31-year-old man with a newly diagnosed platelet-derived growth factor receptor α-rearranged myeloid neoplasm who presented with acute chest pain and elevated cardiac biomarkers. Echocardiography showed Loeffler-type apical involvement, coronary computed tomography angiography excluded obstructive coronary disease, and cardiac magnetic resonance (CMR) demonstrated acute non-ischemic inflammatory myocardial injury. During hospitalization, neurological symptoms revealed central nervous system involvement by the underlying myeloid neoplasm. Corticosteroids and targeted hematologic treatment resulted in marked clinical and radiologic improvement. On long-term follow-up, CMR showed normal cardiac function with complete resolution of the inflammatory myocardial abnormalities and no residual fibrosis. This case highlights the value of early multimodality cardiac imaging, etiologic diagnosis, and coordinated cardio-hematologic management in recognizing potentially reversible eosinophilic myocardial injury and limiting progression to irreversible cardiac sequelae.
No takes yet. Share an insight, caveat, or question.
Aloini et al. (2026) conducted a case report in Eosinophilic myocarditis in PDGFRA-rearranged myeloid neoplasm with central nervous system involvement (n=1). Corticosteroids and targeted hematologic treatment was evaluated on Resolution of inflammatory myocardial abnormalities and normalization of cardiac function on CMR. Corticosteroids and targeted hematologic therapy achieved complete resolution of eosinophilic myocarditis with normal cardiac function and no residual fibrosis in a 31-year-old man (n=1).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: